AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 170 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $528,041 | +43.7% | 21,335 | +64.4% | 0.00% | +100.0% |
| Q2 2023 | $367,537 | +190.3% | 12,978 | +135.5% | 0.00% | – |
| Q1 2023 | $126,588 | +48.4% | 5,511 | +81.5% | 0.00% | – |
| Q4 2022 | $85,279 | +60.9% | 3,037 | +60.8% | 0.00% | – |
| Q3 2022 | $53,000 | -94.0% | 1,889 | -95.3% | 0.00% | -100.0% |
| Q2 2022 | $885,000 | -58.1% | 39,920 | -45.0% | 0.00% | -50.0% |
| Q1 2022 | $2,112,000 | +830.4% | 72,546 | +1376.3% | 0.00% | – |
| Q3 2021 | $227,000 | -50.9% | 4,914 | -53.9% | 0.00% | -100.0% |
| Q4 2020 | $462,000 | +402.2% | 10,661 | +305.8% | 0.00% | – |
| Q3 2020 | $92,000 | -92.7% | 2,627 | -92.6% | 0.00% | -100.0% |
| Q1 2020 | $1,266,000 | +569.8% | 35,677 | +512.2% | 0.01% | +400.0% |
| Q3 2019 | $189,000 | +1790.0% | 5,828 | +2814.0% | 0.00% | – |
| Q2 2019 | $10,000 | -87.3% | 200 | -82.8% | 0.00% | -100.0% |
| Q1 2019 | $79,000 | -65.5% | 1,164 | -76.6% | 0.00% | -50.0% |
| Q4 2018 | $229,000 | -5.0% | 4,976 | +68.6% | 0.00% | 0.0% |
| Q1 2018 | $241,000 | -85.1% | 2,951 | -89.5% | 0.00% | -81.8% |
| Q4 2017 | $1,613,000 | +4.8% | 28,222 | +22.4% | 0.01% | -21.4% |
| Q3 2017 | $1,539,000 | +36.7% | 23,055 | +5.3% | 0.01% | +16.7% |
| Q2 2017 | $1,126,000 | +63.2% | 21,887 | +85.4% | 0.01% | +50.0% |
| Q1 2017 | $690,000 | -23.0% | 11,808 | -45.0% | 0.01% | -11.1% |
| Q4 2016 | $896,000 | +64.4% | 21,462 | +108.2% | 0.01% | +50.0% |
| Q3 2016 | $545,000 | -4.4% | 10,310 | -24.2% | 0.01% | -14.3% |
| Q2 2016 | $570,000 | +9.4% | 13,607 | +6.1% | 0.01% | 0.0% |
| Q1 2016 | $521,000 | +196.0% | 12,825 | +372.0% | 0.01% | +250.0% |
| Q4 2015 | $176,000 | +450.0% | 2,717 | +495.8% | 0.00% | – |
| Q3 2015 | $32,000 | -87.4% | 456 | -83.1% | 0.00% | -100.0% |
| Q1 2015 | $254,000 | -11.2% | 2,695 | +5.6% | 0.00% | 0.0% |
| Q4 2014 | $286,000 | – | 2,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |